November 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreDecember 22, 2025
According to market projections, the tetracyclines market was valued at USD 37.19 billion in 2025 and is expected to reach USD 38.14 billion in 2026, expanding further to USD 47.79 billion by 2035 at a CAGR of 2.54% from 2026 to 2035....
December 22, 2025
Market insights predict the global liquid probiotics for women industry will increase from USD 2.17 billion in 2025 to USD 3.91 billion by 2035, achieving a CAGR of 6.04%. The liquid probiotics for women market is increasing rapidly, as it is easier to consume and potentially has rapid absorption. Probiotic products support improving skin hea...
December 22, 2025
Market insights predict the global antibody drug conjugate (ADC) industry will increase from USD 13.51 billion in 2025 to USD 32.66 billion by 2035, achieving a CAGR of 9.23%. The rising number of cancer cases and the rising need for safe, efficient medications are anticipated to fuel market expansion....
December 22, 2025
Projections indicate that, microbial fermentation technology industry is projected to rise from USD 38.21 billion in 2025 to USD 67.4 billion by 2035, reflecting a CAGR of 5.84% over the next decade. The market is growing due to increasing demand for biologics....
December 22, 2025
Based on market forecasts, the chronic obstructive pulmonary disease sector will expand from USD 22.55 billion in 2024 to USD 34.76 billion by 2034, experiencing a CAGR of 4.42%. In 2023, North America led the COPD market, with chronic bronchitis and drug treatments taking the top spots. Hospitals and clinics were the key end users. Looking ahead, ...
December 22, 2025
Projections indicate that, the global anxiety disorders treatment market will increase from USD 11.9 billion in 2024 to USD 16.95 billion by 2034, experiencing a CAGR of 3.6% over the next 10 years. Anxiety disorder treatment helps manage excessive worry and fear through therapy, medication, or lifestyle changes. Common options include cognitive be...
December 22, 2025
According to market projections, the global Parkinson’s disease diagnosis and treatment market, valued at USD 6.88 billion in 2024, is anticipated to reach USD 16.14 billion by 2034, growing at a CAGR of 8.9% over the next decade. In 2023, medications led the Parkinson’s disease market with a 40% share, while North America dominated at ...
December 22, 2025
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 18.69 billion in 2024 to USD 29.31 billion by 2034, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage by controlling the immune system’s overactive response. Treatments include NSAIDs for pain, ste...
December 22, 2025
Market insights predict the global corticosteroids industry will increase from USD 5.2 billion in 2025 to USD 8.55 billion by 2035, achieving a CAGR of 5.10%. Corticosteroids are anti-inflammatory drugs that help reduce swelling, redness, and immune responses. They treat conditions like asthma, arthritis, allergies, and autoimmune diseases. Availab...
December 22, 2025
According to market projections, the diabetes drugs sector is expected to grow from USD 70.44 billion in 2024 to USD 134.73 billion by 2034, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabetes, with over 537 million adults affected. Factors driving this growth include increased R&D, go...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com